Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-24-000553
Filing Date
2024-08-01
Accepted
2024-08-01 16:11:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4072
  Complete submission text file 0001969223-24-000553.txt   5561
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-14656 | Film No.: 241166811
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REPLIGEN CORPORATION 41 SYON ST. BLDG. 1, SUITE 100 WALTHAM MA 02453
Business Address
Gebski Christine (Reporting) CIK: 0001849585 (see all company filings)

Type: 144